(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 38.31%36.48B | 21.24%129.96B | 29.50%92.14B | 28.58%56.18B | 26.00%26.37B | 20.36%107.19B | 7.92%71.16B | -1.88%43.69B | 5.24%20.93B | 21.79%89.06B |
Operating income | 21.24%129.96B | 28.58%56.18B | 20.36%107.19B | -1.88%43.69B | 21.79%89.06B | |||||
Cost of sales | ---- | -18.53%-119.52B | ---- | -25.16%-51.77B | ---- | -21.45%-100.84B | ---- | 0.25%-41.37B | ---- | -30.77%-83.03B |
Operating expenses | -18.53%-119.52B | -25.16%-51.77B | -21.45%-100.84B | 0.25%-41.37B | -30.77%-83.03B | |||||
Gross profit | 23.59%2.51B | 64.31%10.43B | 91.62%7.9B | 89.37%4.41B | 77.37%2.03B | 5.33%6.35B | -10.42%4.12B | -23.94%2.33B | -10.69%1.14B | -37.38%6.03B |
Selling expenses | ---- | -34.39%-719.58M | ---- | -43.08%-290.24M | ---- | -95.00%-535.44M | ---- | -71.72%-202.84M | ---- | -15.93%-274.58M |
Administrative expenses | ---- | -4.31%-1.29B | ---- | -11.03%-630.68M | ---- | -18.55%-1.23B | ---- | -38.78%-568.04M | ---- | -54.69%-1.04B |
Research and development expenses | ---- | -18.95%-4.72B | ---- | -62.33%-2.46B | ---- | -19.98%-3.97B | ---- | -1.62%-1.51B | ---- | -13.56%-3.31B |
Impairment and provision | ---- | -682.27%-24.98M | ---- | -1,109.02%-7.28M | ---- | -141.01%-3.19M | ---- | -90.67%721K | ---- | 359.56%7.79M |
-Other impairment is provision | ---- | -682.27%-24.98M | ---- | -1,109.02%-7.28M | ---- | -141.01%-3.19M | ---- | -90.67%721K | ---- | 359.56%7.79M |
Special items of operating profit | ---- | -14.37%1.19B | ---- | 5.46%707.08M | ---- | 26.78%1.39B | ---- | -7.55%670.5M | ---- | 125.59%1.1B |
Operating profit | 143.84%4.87B | 142.24%1.73B | -20.39%2B | -59.81%713.64M | -60.13%2.51B | |||||
Financing cost | ---- | -222.24%-188.61M | ---- | -138.08%-58.82M | ---- | -35.09%-58.53M | ---- | 15.84%-24.7M | ---- | 39.26%-43.33M |
Earning before tax | 141.47%4.68B | 142.39%1.67B | -21.37%1.94B | -60.55%688.94M | -60.37%2.47B | |||||
Tax | ---- | -690.30%-639.77M | ---- | -179.55%-154.14M | ---- | 47.91%-80.95M | ---- | 46.53%-55.14M | ---- | 80.06%-155.41M |
After-tax profit from continuing operations | 117.56%4.04B | 139.15%1.52B | -19.58%1.86B | -61.43%633.8M | -57.55%2.31B | |||||
Earning after tax | 117.56%4.04B | 139.15%1.52B | -19.58%1.86B | -61.43%633.8M | -57.55%2.31B | |||||
Profit attributable to shareholders | 33.01%610.41M | 117.56%4.04B | 146.11%3.04B | 139.15%1.52B | 154.85%458.92M | -19.58%1.86B | -42.66%1.24B | -61.43%633.8M | -77.71%180.07M | -57.55%2.31B |
Basic earnings per share | 35.00%0.27 | 118.29%1.79 | 145.45%1.35 | 139.29%0.67 | 150.00%0.2 | -20.39%0.82 | -42.71%0.55 | -61.64%0.28 | -77.78%0.08 | -57.26%1.03 |
Diluted earnings per share | 35.00%0.27 | 118.29%1.79 | 145.45%1.35 | 139.29%0.67 | 150.00%0.2 | -20.39%0.82 | -42.71%0.55 | -61.64%0.28 | -77.78%0.08 | -57.26%1.03 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data